Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study.
Takuma KatoAkira YokomizoRyuji MatsumotoYoichiro TohiJimpei MiyakawaKoji MitsuzukaHiroshi SasakiJunichi InokuchiMasafumi MatsumuraShinichi SakamotoHidefumi KinoshitaHiroshi FukuharaNaoto KamiyaRyu KimuraMasahiro NittaHiroshi OkunoKoichiro AkakuraYoshiyuki KakehiMikio SugimotoPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)
Expanding active surveillance to eligible patients with prostate cancer helps save medical costs.